Aurobindo Pharma Limited (APL), one of the worlds top ... As at June 13th of the year 2007 the Company unveiled their new Logo and Corporate Identity at a ceremony in Hyderabad.

Generic drugmaker Aurobindo Pharma, through wholly owned subsidiary Apitoria on Friday, announced the launch of a six-month post-graduation certification in leadership (CLP) programme at the ...

On the stocks to buy front, Sachin Gupta recommends Aurobindo Pharma Ltd, and Bharat Dynamics Ltd. Here's what Gupta says about the stock market. Nifty 50 rose by 0.5% today, driven primarily by ...

Stock Market Today: Nifty Pharma Index saw steep cuts of more than 1.8% in the morning trades on Tuesday amidst Trump Tariff concerns: Aurobindo, Cipla, Lupin share prices were among key losers ...

Aurobindo’s wholly owned subsidiary, Eugia Pharma Specialities, has received the Food and Drug Administration’s permission to manufacture and market dasatinib tablets, in dosage strengths of 20 mg, 50 ...

Aurobindo Pharma subsidiary CuraTeQ Biologics s.r.o. has received marketing authorisation for Zefylti, its filgrastim biosimilar version, from Medicines and Healthcare products Regulatory Agency ...

Aurobindo Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1196.4. The stock has experienced fluctuations today ...

The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.

WASHINGTON, DC (IANS) – Drug makers Dr Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues. According to the latest ...

The Aurobindo Pharma EPS (TTM) is 59.81. When Is The Next Aurobindo Pharma Earnings Date? Aurobindo Pharma will release its next earnings report on Aug 07, 2025.

Shares of Lupin, Cipla, Natco Pharma, Aurobindo Pharma were down by around 2 per cent today. According to reports, the executive order signed by Trump directs the US Food and Drug Administration ...